Clinical investigations have demonstrated that low circulating levels of IGFBP-1 are associated with type 2 diabetes (T2D) [12-14], whereas high serum IGFBP-1 levels are associated with T1D [15,16]. This evidence concerns the gene IGFBP1 and type 1 diabetes mellitus.